The store will not work correctly when cookies are disabled.
(E)-3-(4-hydroxyphenyl)-1-(5-propylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288599
PubChem CID: 6474718
Max Phase: Preclinical
Molecular Formula: C16H16N2O2
Molecular Weight: 268.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCc1cnc(C(=O)/C=C/c2ccc(O)cc2)cn1
Standard InChI: InChI=1S/C16H16N2O2/c1-2-3-13-10-18-15(11-17-13)16(20)9-6-12-4-7-14(19)8-5-12/h4-11,19H,2-3H2,1H3/b9-6+
Standard InChI Key: TWWXJHDCUAAWEL-RMKNXTFCSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
35.1997 -11.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1986 -11.8392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9066 -12.2482 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6163 -11.8387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6134 -11.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9048 -10.6108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3196 -10.6048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0289 -11.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3165 -9.7876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.7350 -10.5995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4443 -11.0054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4442 -11.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1527 -12.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8598 -11.8160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8541 -10.9946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1451 -10.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5696 -12.2210 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4905 -12.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4899 -13.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7819 -13.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
2 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.32 | Molecular Weight (Monoisotopic): 268.1212 | AlogP: 3.03 | #Rotatable Bonds: 5 |
Polar Surface Area: 63.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.03 | CX Basic pKa: 0.02 | CX LogP: 2.81 | CX LogD: 2.80 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -0.09 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |